← Leaderboards
Eric Kirk Lau
Sanford Burnham Prebys Medical Discovery Institute
$3,439,214
Attributed
$3,439,214
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $457.9K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,439,214 · 4
By mechanism
R01$2,069,678 · 1
R00$735,214 · 1
R21$418,646 · 1
K99$215,676 · 1
Top collaborators
No co-investigators on record.
Most similar at Sanford Burnham Prebys Medical Discovery Institute
Same institution · by research overlap
- Svasti Haricharan$1,765,873
- Elena B Pasquale$23,453,916
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingImmunotherapyProteinsSignal TransductionMelanoma CellMalignant NeoplasmsMelanomaResponseTumorBiologicalCellular BiologyResistanceSkin CancerDiagnosisCellsAffectReportingModalityNovel TherapeuticsBaseImmunePlantsFucoseDietary Sugars
Grant awards (13)
Title of Project * L-fucose-mediated enrichment of memory CD4+T cells and enhanced anti-melanoma immunity$182,325
R21 · FY2025 · CA · contact PI
L-fucose-mediated enrichment of memory CD4+T cells and enhanced anti-melanoma immunity$236,321
R21 · FY2024 · CA · contact PI
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation$385,581
R01 · FY2023 · CA · contact PI
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation$385,581
R01 · FY2022 · CA · contact PI
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation$457,861
R01 · FY2021 · CA · contact PI
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation$393,450
R01 · FY2020 · CA · contact PI
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation$64,411
R01 · FY2020 · CA · contact PI
Enhancing TIL populations and immunotherapy efficacy in melanoma by modulating fucosylation$382,794
R01 · FY2019 · CA · contact PI
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma$239,410
R00 · FY2017 · CA · contact PI
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma$246,805
R00 · FY2016 · CA · contact PI
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma$248,999
R00 · FY2015 · CA · contact PI
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma$107,838
K99 · FY2014 · CA · contact PI
The PKCepsilon-regulated oncogenic and tumor suppressor roles of ATF2 in melanoma$107,838
K99 · FY2013 · CA · contact PI